Abstract
Background and Objective: Hip and knee osteoarthritis is highly prevalent in the elderly, and the incidence is estimated to increase in the coming decades. Prior to surgery, symptomatic treatment, starting with non-pharmacological therapies, should be prescribed. Paracetamol (acetaminophen) is the recommended first pharmacological treatment for osteoarthritis. If paracetamol is ineffective, non-steroidal anti-inflammatory drug (NSAID) treatment is indicated. The superiority of NSAIDs over paracetamol has been demonstrated in several studies. Furthermore, the assessment of patient satisfaction could be an adequate indicator of the quality of care given and is likely related to the evolution of the condition and the therapeutic regimen. The objective of this study was to assess the satisfaction of patients diagnosed with hip and/or knee osteoarthritis who had been previously treated with paracetamol and switched to NSAID treatment due to a lack of effectiveness by paracetamol.
Methods: An observational, prospective, multicentre and comparative study was conducted in 2009 among patients diagnosed with hip and knee OA who visited outpatient orthopaedic clinics. The evaluation of treatment effectiveness was carried out using a patient-based visual analogue scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). The satisfaction regarding change of treatment due to a lack of effectiveness and/or the presence of adverse effects was evaluated using the osteoARthritis Treatment Satisfaction (ARTS) questionnaire.
Results: A total of 2437 patients were evaluated (knee OA: 1438 [59%]; hip OA: 621 [25.5%]; knee and hip OA: 124 [5.1%]; and without OA location registered: 254 [10.4%]). The study findings showed an increase in patient satisfaction after abandoning the use of paracetamol to treat OA. Statistically significant increases in both overall satisfaction mean (from 57.7 [SD 13.5] to 71.3 [SD 12.0]) and in each of the four domains of the ARTS questionnaire were observed (p < 0.0001 in all cases). According to the WOMAC and a VAS, treatment effectiveness increased significantly after 3 months (p < 0.0001) and significant correlations with satisfaction were observed (r = −0.32 and r = −0.29, respectively; p < 0.0001). The mean (SD) change in global satisfaction in patients treated with NSAIDs was 14.9 (15.5) versus 7.2 (14.4) for patients treated with non-NSAIDs (p < 0.0001). Patients taking NSAID treatment showed substantially more improvement over those taking non-NSAID treatment.
Conclusion: NSAIDs relieve pain due to O A in paracetamol-resistant patients and improve treatment effectiveness and patient satisfaction with treatment. Furthermore, paracetamol-refractory subjects under conventional medical treatment with NSAIDs experienced the drug as more effective and also tended to be more satisfied with treatment than those treated with non-NSAIDs.
Similar content being viewed by others
References
Felson DT, Naimark A, Anderson J, et al. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum 1987 Aug; 30(8): 914–8
Verbrugge LM. Disability transitions for older persons with arthritis. J Aging Health 1992 May; 4: 212–3
Rudman D. Nutrition and fitness in elderly people. Am J Clin Nutr 1989 May; 49: 1090–8
Harris T, Kovar MG, Suzman R, et al. Longitudinal study of physical ability in the oldest old. Am Public Health 1989 Jun; 79: 698–702
Crimmins EM, Saito Y. Getting better and worse: transitions in functional status among older Americans. J Aging Health 1993 February; 5: 3–36
Haq I, Murphy E, Dacre J. Osteoarthritis. Postgrad Med J 2003 March; 79(933): 377–83
Badley EM, Wang PP. Arthritis and the aging population: projections of arthritis prevalence in Canada 1991 to 2013. J Rheumatol 1998 Jan; 25(1): 138–44
Berenbaum F. New horizons and perspectives in the treatment of osteoarthritis. Arthritis Res Ther 2008 October; 10 Suppl. 2: S1–7
Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006 May; 10: 287–333
Moskowitz R, Howell D, Altman R, et al. Osteoarthritis: diagnosis and medical/surgical management, 3rd ed. Philadelphia (PA): W.B. Saunders, 2001
Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986 Aug; 29: 1039–49
Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957 Dec; 16(4): 494–502
American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 2000; 43: 1905–15
National Collaborating Centre for Chronic Conditions. Osteoarthritis: national clinical guideline for care and management in adults. London: Royal College of Physicians, 2008
Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003 Dec; 62(12): 1145–55
Alonso A, Ballina FJ, Batlle E, et al. Primer documento de consenso de la Sociedad Española de Reumatología sobre el tratamiento de la artrosis de rodilla. Reumatol Clin 2005; 1(1): 38–48
Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007 Sep; 15: 981–1000
Geba GP, Weaver AL, Polis AB, et al. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA 2002 Jan; 287(1): 64–71
Pincus T, Koch G, Lei H, et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Ann Rheum Dis 2004 Aug; 63(8): 931–9
Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006 Jan 25; 1: CD004257
Pavelka K. Symptomatic treatment of osteoarthritis: paracetamol or NSAIDs? Int J Clin Pract Suppl. 2004 Oct; 144: 5–12
Pincus T, Swearingen C, Cummins P, et al. Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol 2000 Apr; 27(4): 1020–7
Wolfe F, Zhao S, Lane N. Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000 Feb; 43(2): 378–85
McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum 2001 Oct; 45(5): 453–61
Escobar A, Quintana JM, Bilbao A, et al. Validation of the Spanish version of the WOMAC questionnaire for patients with hip or knee osteoarthritis. Western Ontario and McMaster Universities Osteoarthritis Index. Clin Rheumatol 2002 Nov; 21(6): 466–71
Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 1990 Aug; 13(4): 227–36
Pouchot J, Trudeau E, Hellot SC, et al. Development and psychometric validation of a new patient satisfaction instrument: the osteoARthritis Treatment Satisfaction (ARTS) questionnaire. Qual Life Res 2005 Jun; 14(5): 1387–99
Rejas J, Monfort J, Campillo MA, et al. Criterion validity of the ARthritis Treatment Satisfaction (ARTS) questionnaire: patient satisfaction with treatment and need for switching therapy. Clin Drug Investig 2009 Aug; 29(8): 527–38
Ruiz M, Campillo MA, Monfort J, et al. Linguistic adaptation into Spanish and validation of the Arthritis Treatment Satisfaction Questionnaire. Med Clin (Barc) 2005 Jun; 125(3): 84–92
Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989 Mar; 27: S178–89
Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003 Nov; 81: 646–56
Bradley JD, Brandt KD, Katz BP, et al. Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. J Rheumatol 1992 Dec; 19: 1950–4
Williams HJ, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993 Sep; 36: 1196–206
Pincus T, Koch GG, Sokka T, et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001 Jul; 44(7): 1587–98
Lee C, Straus WL, Balshaw R, et al. A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. Arthritis Rheum 2004 Oct; 51(5): 746–54
Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis 2004 Aug; 63: 901–7
Ware Jr JE, Davies AR. Behavioral consequences of consumer dissatisfaction with medical care. Eval Program Plann 1983; 6(3–4): 291–7
Ware Jr JE, Snyder MK, Wright WR, et al. Defining and measuring patient satisfaction with medical care. Eval Program Plann 1983; 6(3–4): 247–63
Woodside AG, Frey LL, Daly RT. Linking service quality, customer satisfaction, and behavioral intention. J Health Care Mark 1989 Dec; 9(4): 5–17
Jackson JL, Chamberlin J, Kroenke K. Predictors of patient satisfaction. Soc Sci Med 2001 Feb; 52(4): 609–20
Renzi C, Abeni D, Picardi A, et al. Factors associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol 2001 Oct; 145(4): 617–23
Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000 Jul; 20(6): 554–60
Acknowledgements
We are grateful to all the patients and doctors who voluntarily contributed to the development of this study. We also thank Consuelo Escudero for facilitating the authors’ work.
Competing Interests
Pfizer S.L.U. funded the study. AOA, MTM and MARI declare no conflicts of interest. BA and JR are Pfizer employees.
Authors’ Contributions
AOA and BA participated in the design of this study, data interpretation and the writing of this manuscript. MTM, MARI and JR participated in the preparation of the manuscript, data interpretation, and the literature review and extraction. All authors had full access to the data and have provided their final approval of the version to be published.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oteo-Álvaro, Á., Marín, M.T., Ruiz-Ibán, M.A. et al. Treatment Satisfaction after Switching to Another Therapy in Spanish Orthopaedic Clinic Outpatients with Knee or Hip Osteoarthritis Previously Refractory to Paracetamol. Clin Drug Investig 32, 685–695 (2012). https://doi.org/10.1007/BF03261922
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03261922